Archives of Medical Research
Volume 41, Issue 2 , Pages 125-133 , February 2010

Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer: A Meta-analysis

  • Xingli Dong

      Affiliations

    • Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China
    • Biopharmaceutical Key Laboratory of Heilongjiang Province-Incubator of State Key Laboratory, Harbin, China
    • These authors contributed equally to this work.
  • ,
  • Jianing Wu

      Affiliations

    • Neurosurgery Department, First Affiliated Hospital of Harbin Medical University, Harbin, China
    • These authors contributed equally to this work.
  • ,
  • Peng Liang

      Affiliations

    • Neurosurgery Department, First Affiliated Hospital of Harbin Medical University, Harbin, China
  • ,
  • Jihong Li

      Affiliations

    • Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China
    • Biopharmaceutical Key Laboratory of Heilongjiang Province-Incubator of State Key Laboratory, Harbin, China
  • ,
  • Lijie Yuan

      Affiliations

    • Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China
    • Biopharmaceutical Key Laboratory of Heilongjiang Province-Incubator of State Key Laboratory, Harbin, China
  • ,
  • Xinghan Liu

      Affiliations

    • Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China
    • Biopharmaceutical Key Laboratory of Heilongjiang Province-Incubator of State Key Laboratory, Harbin, China
    • Corresponding Author InformationAddress reprint requests to: Xinghan Liu, Biopharmaceutical Key Laboratory of Heilongjiang Province-Incubator of State Key Laboratory, Harbin Medical University, Harbin, Heilongjiang, 150081, China; Phone: 86-451-86676570; FAX: 86-451-86677243

Received 16 October 2009 ,Accepted 16 December 2009.

References 

  1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354–362
  2. Torres J, Lopez L, Lazcano E, et al. Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol Biomarkers Prev. 2005;14:1874–1877
  3. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer. 2002;100:249–260
  4. Zhang FF, Terry MB, Hou L, et al. Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:115–121
  5. Stern LL, Mason JB, Selhub J, et al. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev. 2000;9:849–853
  6. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
  7. Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169–172
  8. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost. 1997;78:523–526
  9. Parle-McDermott A, Mills JL, Molloy AM, et al. The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab. 2006;88:290–294
  10. Friedman G, Goldschmidt N, Friedlander Y, et al. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr. 1999;129:1656–1661
  11. Klerk M, Verhoef P, Clarke R, et al. MTHFR 677C/T polymorphism and risk of coronary heart disease: a metaanalysis. JAMA. 2002;288:2023–2031
  12. Lievers KJ, Boers GH, Verhoef P, et al. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med. 2001;79:522–528
  13. Chango A, Boisson F, Barbe F, et al. The effect of 677C/T and 1298A/C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr. 2000;83:593–596
  14. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123–137
  15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
  16. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–826
  17. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statist Med. 2006;25:3443–3457
  18. Gao CM, Lu JW, Toshiro T, et al. Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:1054–1058
  19. Gao CM, Takezaki T, Wu JZ, et al. Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac J Cancer Prev. 2004;5:133–138
  20. Gao CM, Wu JZ, Liu YT, et al. Interactions between lifestyle, methylanetetrahydrofolate reductase gene and polymorphisms in thymidylate synthase gene with risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24:599–603
  21. Mu LN, Ding BG, Chen CW, et al. A case-control study on the relationship between methyl-tetra-hydrofolic acid reductase 677 gene polymorphism and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:495–498
  22. Miao X, Xing D, Tan W, et al. Single nucleotide polymorphisms in methylenetetrahydrofolate reductase gene and susceptibility to cancer of the gastric cardia in Chinese population. Zhonghua Yi Xue Za Zhi. 2002;82:669–672
  23. Shen H, Xu Y, Zheng Y, et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 2001;95:332–336
  24. Gao C, Wu J, Ding J, et al. Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23:289–292
  25. Mu LN, Cao W, Zhang ZF, et al. Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer. Biomarkers. 2007;12:61–75
  26. Miao X, Xing D, Tan W, et al. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev. 2002;11:1454–1458
  27. Shen H, Newmann AS, Hu Z, et al. Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. Oncol Rep. 2005;13:355–360
  28. Bi JP, Cai L, Zheng ZL. Study on C667T gene polymorphism and susceptibility to gastric cancer. Chin J Public Health. 2005;21:661–663
  29. Sun L, Sun YH, Wang B, et al. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis. Eur J Cancer Prev. 2008;17:446–452
  30. Boccia S, Gianfagna F, Persiani R, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers. 2007;12:635–644
  31. Gotze T, Rocken C, Rohl FW, et al. Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett. 2007;251:228–236
  32. Graziano F, Kawakami K, Ruzzo A, et al. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer. 2006;118:628–632
  33. Sarbia M, Geddert H, Kiel S, et al. Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract. Scand J Gastroenterol. 2005;40:109–111
  34. Li S, Ji M, He N, et al. Application of microarray-based method for methylenetetrahydrofolate reductase (MTHFR) polymorphisms in the risk of gastric carcinoma in east China population. J Nanosci Nanotechnol. 2007;7:3245–3249
  35. Wang Y, Guo W, He Y, et al. Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control. 2007;18:143–152
  36. Weng YR, Sun DF, Fang JY, et al. Folate levels in mucosal tissue but not methylenetetrahydrofolate reductase polymorphisms are associated with gastric carcinogenesis. World J Gastroenterol. 2006;12:7591–7597
  37. Si PR, Fang DC, Zhang H, et al. The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26:794–799
  38. Kim JK, Kim S, Han JH, et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res. 2005;25:2249–2252
  39. Wang LD, Guo RF, Fan ZM, et al. Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus. 2005;18:177–184
  40. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B12-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev. 2003;12:1222–1226
  41. Galvan-Portillo MV, Cantoral A, Onate-Ocana LF, et al. Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers. Eur J Nutr. 2009;48:269–276
  42. Zuniga-Noriega JR, Velazco-Campos M, del R, Aguirre-Rodriguez A, et al. C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population. Rev Gastroenterol Mex. 2007;72:355–358
  43. Lacasana-Navarro M, Galvan-Portillo M, Chen J, et al. Methylenetetrahydrofolate reductase 677C >T polymorphism and gastric cancer susceptibility in Mexico. Eur J Cancer. 2006;42:528–533
  44. Vollset SE, Igland J, Jenab M, et al. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2007;16:2416–2424
  45. Zeybek U, Yaylim I, Yilmaz H, et al. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct. 2007;25:419–422
  46. Boccia S, Hung R, Ricciardi G, et al. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol. 2008;167:505–516
  47. Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet. 2006;51:618–624
  48. Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology. 2006;131:1271–1283
  49. Kamen B. Folate and antifolate pharmacology. Semin Oncol. 1997;24:S18–30–S18–39
  50. Zintzaras E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet. 2006;69:327–3361
  51. Song C, Xing D, Tan W, et al. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res. 2001;61:3272–3275
  52. Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol. 2000;13:20–33
  53. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
  54. Bailey LB. Folate status assessment. J Nutr. 1990;120(Suppl):1508–1511

PII: S0188-4409(10)00002-0

doi: 10.1016/j.arcmed.2010.01.001

Archives of Medical Research
Volume 41, Issue 2 , Pages 125-133 , February 2010